ENT Technologies Pty Ltd is a wholly Australian owned business which specialises in the formulation, development and delivery of novel pharmaceutical preparations for the management of both acute and chronic pathologies of both nasal and sinus cavities. Our activities are now expanding to novel leading treatments for the oropharynx and larynx. ENT Technologies has pioneered the introduction of FLO nasal and sinus products. Included in the range are sterile, preservative-free multidose nasal sprays and preservative free sinus irrigations tailored for specific sinus pathologies. The ENT Technologies team welcomes opportunities to provide support for research and development, as it is an area in which it is very active with both its own projects and those put forward by various ENT research oriented units across Australia. For more information please contact: ENT Technologies Pty Ltd Dr Sam Barbalatt Medical Director M: 0413 610 966 E: sam@enttech.com.au W: enttech.com.au